Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
University of Groningen · University Medical Center Groningen · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
690
total citations
- FWCI
- 44.35
- Percentile
- 100%
- References
- 39
Citations per year
Authors
11- DDDick de ZeeuwCorresponding
University of Groningen, University Medical Center Groningen
- RARajiv Agarwal
Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
- MAMichael Amdahl
Abbott (United Kingdom)
- PAPaul Audhya
Abbott (United Kingdom)
- DWDaniel W. Coyne
Washington University in St. Louis
Topics & keywords
Topics
Keywords
- Paricalcitol
- Medicine
- Albuminuria
- Placebo
- Urology
- Type 2 diabetes
- Internal medicine
- Diabetes mellitus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.